MedPath
FDA Approval

Ceftriaxone Sodium

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Hospira, Inc
DUNS: 141588017
Effective Date
January 10, 2024
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Ceftriaxone(1 g in 1 1)

Products4

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ceftriaxone Sodium

Product Details

NDC Product Code
0409-7332
Application Number
ANDA065169
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS, INTRAMUSCULAR
Effective Date
June 15, 2017
Code: 023Z5BR09KClass: ACTIMQuantity: 1 g in 1 1

Ceftriaxone Sodium

Product Details

NDC Product Code
0409-7337
Application Number
ANDA065169
Marketing Category
ANDA (C73584)
Route of Administration
INTRAMUSCULAR, INTRAVENOUS
Effective Date
June 15, 2017
Code: 023Z5BR09KClass: ACTIMQuantity: 250 mg in 1 1

Ceftriaxone Sodium

Product Details

NDC Product Code
0409-7338
Application Number
ANDA065169
Marketing Category
ANDA (C73584)
Route of Administration
INTRAMUSCULAR, INTRAVENOUS
Effective Date
June 15, 2017
Code: 023Z5BR09KClass: ACTIMQuantity: 500 mg in 1 1

Ceftriaxone Sodium

Product Details

NDC Product Code
0409-7335
Application Number
ANDA065169
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS, INTRAMUSCULAR
Effective Date
June 15, 2017
Code: 023Z5BR09KClass: ACTIMQuantity: 2 g in 1 1
© Copyright 2025. All Rights Reserved by MedPath